1 year return (CAGR)
-23.77%
Audax Renovables S.A. Exchange (MC, EUR)
ADX.MC
1.04
+0.01 (+0.57%)
UtilitiesUtilities - Renewable
Loading...
3 year return (CAGR)
-2.07%
5 year return (CAGR)
-3.95%
10 year return (CAGR)
8.62%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
467.94M
Price/Sales
0.25
Ent value
1.35B
Price/Book
1.98
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-1.24%
Trailing P/E
39.17
PEG
-
Forward P/E
9.56
EPS growth
-6.20%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.05 |
| Daily high | 1.05 |
| Daily low | 1.04 |
| Daily Volume | 89K |
| All-time high | 9.72 |
| 1y analyst estimate | 2.35 |
| Beta | 1.15 |
| EPS (TTM) | 0.03 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2026 |
| Next earnings date | 28 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ADX.MC | S&P500 | |
| Current price drop from All-time high | -89.28% | -3.18% |
| Highest price drop | -97.22% | -56.47% |
| Date of highest drop | 25 Apr 2013 | 9 Mar 2009 |
| Avg drop from high | -80.35% | -10.65% |
| Avg time to new high | 71 days | 12 days |
| Max time to new high | 4926 days | 1805 days |
News
Tomas Okmanas, who has served as a member of the Supervisory Council of Artea Bank since 2 February 2023, has decided to step down from the Supervisory Council. T. Okmanas made this decision taking in...
November 4, 2026
Four biotech stocks, including TG Therapeutics and Immunome, show positive Earnings ESPs and favorable Zacks Ranks, positioning them for potential third-quarter earnings beats.
November 4, 2026
Operating margins are on track to hit 40% by 2029 as cost discipline accelerates alongside new drug launches.
November 4, 2026
Ramsay Générale de Santé has seen its share price under pressure in recent years, which naturally puts the focus on whether the current €8.80 level is adequately explained by the revenue it generates....
November 3, 2026
The Q3 earnings cycle continues to roll along, with several healthcare companies delivering positive results and raising their outlooks as a result.
November 2, 2026
Jungfraubahn Holding has delivered a 105.3% share price gain over the past 5 years, which naturally puts the spotlight on whether the current Swiss franc price is adequately backed by the cash the bus...
November 2, 2026
European energy policy has taken an unexpected twist, with talk of Russian gas potentially returning to the continent through a U.S. intermediary just as winter demand builds. Lower gas and power pric...
November 2, 2026
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that Novartis Pharma AG has notified BioArctic that it has decided to terminate the Option, Collaboration and License Agreement entered i...
November 2, 2026
PARIS, November 02, 2026--Regulatory News: Gecina (Paris:GFC):
November 2, 2026
Press release - Regulated Information Melexis: update on the share buy-back program Ieper, Belgium – 2 November 2026, 17.45 hrs CET Melexis reports the purchase of 9,800 Melexis shares on Euronext Bru...
November 2, 2026